COR vs PODD · P/E 21, rev $321.33B vs P/E 34, rev $2.07B
Cencora Inc. (COR) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
COR currently screens at market cap $53.91B and trailing P/E 21.2. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the COR and PODD stock pages for the full models.
Not investment advice.